394 related articles for article (PubMed ID: 18609108)
21. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
22. [Dimorphous cancer of the lung].
Briusov PG; Leonova VV
Vopr Onkol; 1997; 43(2):205-7. PubMed ID: 9214124
[TBL] [Abstract][Full Text] [Related]
23. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
24. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data.
Miao Q; Lei S; Chen F; Niu Q; Luo H; Cai B
BMC Cancer; 2024 May; 24(1):657. PubMed ID: 38811867
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of serum tumor markers in asymptomatic individuals.
Eleftheriadis N; Papaloukas C; Pistevou-Gompaki K
J BUON; 2009; 14(4):707-10. PubMed ID: 20148467
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract][Full Text] [Related]
28. Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI™-based Assays.
Dolscheid-Pommerich RC; Manekeller S; Walgenbach-Brünagel G; Kalff JC; Hartmann G; Wagner BS; Holdenrieder S
Anticancer Res; 2017 Jan; 37(1):353-359. PubMed ID: 28011514
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
30. Multicentre tumour marker reference range study.
Wilson AP; Van Dalen A; Sibley PE; Kasper LA; Durham AP; el Shami AS
Anticancer Res; 1999; 19(4A):2749-52. PubMed ID: 10470234
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
34. Effect of the coronavirus pandemic on tumor markers.
Purut YE; Giray B; Gurbuz E
J Med Virol; 2021 Sep; 93(9):5405-5408. PubMed ID: 33932304
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)].
Flaschka G; Marth E; Desoye G; Freidl W; Walzl M
Zentralbl Neurochir; 1990; 51(3):129-37. PubMed ID: 2092546
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
[TBL] [Abstract][Full Text] [Related]
37. CEA, CA125 and CA19-9 levels in congenital gastrointestinal anomalies.
Baykal-Erkiliç A; Erkiliç M; Melikoğlu M; Aksu A
Turk J Pediatr; 1999; 41(4):473-81. PubMed ID: 10770115
[TBL] [Abstract][Full Text] [Related]
38. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
Ng WW; Tong KJ; Tam TN; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer].
Zheng H; He BF; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):165-6. PubMed ID: 12581971
[TBL] [Abstract][Full Text] [Related]
40. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
